NeuroOne Medical Technologies (NMTC) said late Thursday it began a proposed underwritten registered public offering of its shares.
The company will sell all the shares of common stock in the offering.
In addition, the company intends to grant the underwriter a 45-day option to purchase up to an additional 15% of the shares sold in the offering.
Shares NeuroOne Medical were down over 36% in after-hours activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。